Phelan-McDermid Syndrome — NDIS Support
Yes — Phelan-McDermid Syndrome can qualify for NDIS support. PMS is on the NDIA’s List A, so the disability requirement is treated as met — the focus is confirming the diagnosis. Funding covers reasonable and necessary supports across daily living, therapy, social participation and capacity building.
Phelan-McDermid Syndrome (PMS), also known as 22q13.3 deletion syndrome, is a rare genetic condition caused by deletion or disruption of the terminal region of chromosome 22, commonly involving the SHANK3 gene. SHANK3 plays a critical role in synapse formation in the brain, and its loss is one of…
PMS & the NDIS FAQs
- Is Phelan-McDermid Syndrome automatically eligible for NDIS?
- Yes. PMS is a List A condition and is likely to meet NDIS disability requirements automatically. Genetic confirmation — chromosomal microarray or FISH showing the 22q13.3 deletion — from a clinical geneticist is required. Given the complexity and high support needs of PMS, substantial NDIS funding across Core, Capacity…
- Can AAC really help someone with Phelan-McDermid Syndrome who has never spoken?
- Yes. AAC has proven effective even for individuals with very limited verbal communication, including those with PMS. Evidence-based AAC approaches — particularly robust core vocabulary systems using high-tech speech generating devices with partner-assisted scanning or eye gaze access — have enabled many people with PMS…
- What is regression in PMS and how can it be managed?
- Skill regression — loss of previously acquired abilities such as walking, communication or daily living skills — occurs in some adolescents and adults with PMS. It may be triggered by illness, stress, psychiatric episodes or be idiopathic. When regression occurs, prompt medical review (to rule out seizure activity or…
- Are there Australia-specific resources for PMS families?
- The Phelan-McDermid Syndrome Foundation Australia supports Australian families with information, connection and advocacy. Specialist genetic clinics in major Australian cities (Sydney, Melbourne, Brisbane, Perth, Adelaide) can provide ongoing clinical management. NDIS support coordination from coordinators with…
- How is ASD in PMS different from idiopathic ASD?
- ASD features in PMS arise from the specific genetic disruption of the SHANK3 gene, which affects synapse function. The ASD profile in PMS is characterised by profound communication impairment, social interest (unlike classic ASD where social withdrawal is typical), hypotonia, and regression risk. While the NDIS…
PMS & the NDIS — practical guides
- Applying for the NDIS with Phelan-McDermid Syndrome
- Assistive Technology for Phelan-McDermid Syndrome
- Day Programs & Community Participation for Phelan-McDermid Syndrome
- NDIS Early Childhood & School Support for Phelan-McDermid Syndrome
- NDIS Funding & Budget for Phelan-McDermid Syndrome
- Therapy & Allied Health for Phelan-McDermid Syndrome
- Specialist Disability Accommodation (SDA) for Phelan-McDermid Syndrome
- Supported Independent Living (SIL) for Phelan-McDermid Syndrome
- Finding & Managing Support Workers for Phelan-McDermid Syndrome
Related conditions
- CHARGE Syndrome and the NDIS
- Cri du Chat Syndrome and the NDIS
- Kabuki Syndrome and the NDIS
- Costello Syndrome and the NDIS
- Klinefelter Syndrome and the NDIS
- Phenylketonuria (PKU) and the NDIS
- Neurofibromatosis and the NDIS
- Acquired Brain Injury and the NDIS
- Cerebral Palsy and the NDIS
- Epilepsy and the NDIS
Sources
Reviewed by the Novida editorial team · last reviewed 2026-07-12. General information only — not medical advice.